Time
Days to earnings16
Next print2026-11-03
WindowAMC
Fiscal2026-09-30
NASDAQ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
AMGN
Amgen Inc primary
417.57
Full stocks workspace →+10.13+2.5%
Street
Consensus EPS5.781
Consensus revenue10.0B
EPS high / low6.164 / 5.48 · 11.8% · n=27
Rev / avg0 / — · 5.781 / 5.781
Options
IV front26.9%
Implied move6.6%
Put/call full1.04
Put/call front1.32
Short interest
Short shares14.0M / 14.1M · -0.25%
Days to cover4.10
Avg vol · float3.4M · 538.2M
Short % float2.61%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 16 | 2026-11-03 | 417.57 | 5.781 | 26.9% | 6.6% | +3.6% | -0.1% | +9.5% | -3.4% | 6.164 / 5.48 | 11.8% | 27 | 1.04 | 0 | |
| 2026-10-08 | 18 | 2026-11-03 | 407.44 | 5.781 | 26.9% | 7.2% | +0.0% | +0.3% | +6.5% | -7.5% | 6.164 / 5.48 | 11.8% | 27 | 1.04 | 0 | |
| 2026-10-07 | 19 | 2026-11-03 | 413.08 | 5.781 | 26.9% | 7.3% | -2.0% | +1.7% | +5.6% | -6.6% | 6.164 / 5.48 | 11.8% | 27 | 1.04 | 0 | |
| 2026-10-06 | 20 | 2026-11-03 | 402.60 | 5.781 | 26.4% | 7.3% | -5.0% | -1.9% | +2.4% | -9.3% | 6.164 / 5.48 | 11.8% | 27 | 1.04 | 0 | |
| 2026-10-05 | 21 | 2026-11-03 | 402.98 | 5.781 | 24.4% | 6.9% | -3.6% | +2.5% | -7.8% | -8.3% | 6.164 / 5.48 | 11.8% | 27 | 1.05 | 0 | |
| 2026-10-02 | 22 | 2026-11-03 | 403.04 | 5.781 | 26.9% | 8.0% | -2.8% | +4.5% | -9.2% | -7.1% | 6.164 / 5.48 | 11.8% | 27 | 1.08 | 0 | |
| 2026-10-01 | 23 | 2026-11-03 | 407.27 | 5.781 | 27.3% | 8.2% | +0.3% | +7.2% | -8.0% | -7.9% | 6.164 / 5.48 | 11.8% | 27 | 1.09 | 0 | |
| 2026-09-30 | 24 | 2026-11-03 | 421.51 | 5.781 | 26.9% | 8.2% | +3.8% | +12.0% | -3.8% | -0.9% | 6.164 / 5.48 | 11.8% | 27 | 1.09 | 0 | |
| 2026-09-29 | 25 | 2026-11-03 | 423.64 | 5.781 | 27.3% | 8.5% | +3.3% | +12.8% | -1.5% | +1.0% | 6.164 / 5.48 | 11.8% | 27 | 1.09 | 0 | |
| 2026-09-28 | 26 | 2026-11-03 | 418.13 | 5.781 | 24.9% | 7.8% | +6.4% | +9.6% | -3.3% | +0.7% | 6.164 / 5.48 | 11.8% | 27 | 1.11 | 0 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| VRTX primary | Vertex Pharmaceuticals Inc | 0.51 | 2026Q2 · 2026-08-03 | +1.2% | +0.1% | 478.71 | 15 · 2026-10-12 |
| REGN primary | Regeneron Pharmaceuticals Inc | 0.49 | 2026Q2 · 2026-07-30 | +56.6% | +0.9% | 738.34 | 14 · 2026-10-12 |
| GILD primary | Gilead Sciences Inc | 0.47 | 2026Q2 · 2026-08-03 | +4.5% | 0.0% | 135.25 | 13 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-08-04 | AMC | 6.29 | +12.3% | Beat | +0.9% | +3.7% | 2.03× | +8.5% | Review |
| 2026Q1 | 2026-04-30 | AMC | 5.15 | +8.0% | Beat | -4.0% | -0.8% | 1.51× | -1.1% | Review |
| 2025Q4 | 2026-02-03 | AMC | 5.29 | +11.8% | Beat | +4.0% | +4.0% | 2.01× | +2.5% | Review |
| 2025Q3 | 2025-11-04 | AMC | 5.64 | +12.6% | Beat | +2.2% | +5.5% | 2.45× | +7.0% | Review |
| 2025Q2 | 2025-08-05 | AMC | 6.02 | +14.0% | Beat | -1.5% | -3.7% | 2.37× | +4.1% | Review |
| 2025Q1 | 2025-05-01 | AMC | 4.90 | +15.0% | Beat | +2.7% | -3.5% | 1.82× | -3.1% | Review |
| 2024Q4 | 2025-02-04 | AMC | 5.31 | +4.5% | Beat | +0.6% | +5.9% | 1.91× | -3.2% | Review |
| 2024Q3 | 2024-10-30 | AMC | 5.58 | +9.2% | Beat | +0.7% | +0.8% | 1.62× | -7.6% | Review |
| 2024Q2 | 2024-08-06 | AMC | 4.97 | -0.6% | Miss | -2.4% | -2.6% | 2.13× | +5.3% | Review |
| 2024Q1 | 2024-05-02 | AMC | 3.96 | +1.8% | Beat | +12.6% | -0.7% | 3.80× | +0.4% | Review |